Morgan Stanley’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $497K | Buy |
49,773
+29,789
| +149% | +$298K | ﹤0.01% | 5459 |
|
|
2025
Q1 | $1.76M | Sell |
19,984
-2,489
| -11% | -$219K | ﹤0.01% | 4687 |
|
|
2024
Q4 | $2.08M | Buy |
22,473
+12,931
| +136% | +$1.2M | ﹤0.01% | 4671 |
|
|
2024
Q3 | $698K | Buy |
9,542
+8,063
| +545% | +$590K | ﹤0.01% | 5238 |
|
|
2024
Q2 | $85.9K | Buy |
1,479
+728
| +97% | +$42.3K | ﹤0.01% | 6013 |
|
|
2024
Q1 | $777K | Sell |
751
-1,252
| -63% | -$1.3M | ﹤0.01% | 5105 |
|
|
2023
Q4 | $1.59M | Buy |
2,003
+1,459
| +268% | +$1.16M | ﹤0.01% | 5058 |
|
|
2023
Q3 | $259K | Sell |
544
-400
| -42% | -$190K | ﹤0.01% | 5466 |
|
|
2023
Q2 | $566K | Sell |
944
-341
| -27% | -$205K | ﹤0.01% | 5144 |
|
|
2023
Q1 | $907K | Buy |
1,285
+1,222
| +1,940% | +$863K | ﹤0.01% | 4913 |
|
|
2022
Q4 | $64.2K | Sell |
63
-73
| -54% | -$74.4K | ﹤0.01% | 6181 |
|
|
2022
Q3 | $78K | Sell |
136
-91
| -40% | -$52.2K | ﹤0.01% | 6204 |
|
|
2022
Q2 | $124K | Buy |
227
+11
| +5% | +$6.01K | ﹤0.01% | 6158 |
|
|
2022
Q1 | $139K | Sell |
216
-11
| -5% | -$7.08K | ﹤0.01% | 6117 |
|
|
2021
Q4 | $94K | Buy |
227
+149
| +191% | +$61.7K | ﹤0.01% | 6483 |
|
|
2021
Q3 | $57K | Buy |
+78
| New | +$57K | ﹤0.01% | 6661 |
|